Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06679049 · ClinicalTrials.gov registry record · NA

Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing

A NA study of Tibial Fractures, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06679049: Recruiting NA study of Tibial Fractures, sponsored by University of Alabama at Birmingham.

NCT06679049 is a NA study of Tibial Fractures that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 332-participant average among 12 other Tibial Fractures trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06679049, a NA study of Tibial Fractures, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to perform a high-quality randomized control trial comparing intramedullary tibial nail fixation with standard design nails to a micromotion tibial nail device, to evaluate the rates of union and post-operative outcomes.

Primary Outcome

bridging callus, minimum three cortices bridged

Conditions Studied

Interventions

  • PROCEDURE micromotion intramedullary nail cohort
  • PROCEDURE standard intramedullary nail cohort

Study Locations (1)

Alabama

  • University of Alabama at Birmingham Main Hospital - Birmingham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-04-30
Est. Completion 2026-12-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06679049 shows while recruiting

NCT06679049 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 12 other Tibial Fractures trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Tibial Fractures appearing as the primary indexed condition, and to 2 interventions - of which micromotion intramedullary nail cohort is the first listed.

NCT06679049 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06679049 about?

NCT06679049 is a clinical study titled "Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing". The primary purpose of this study is to perform a high-quality randomized control trial comparing intramedullary tibial nail fixation with standard design nails to a micromotion tibial nail device, to evaluate the rates of union and post-operative outcomes.

What is the current status of trial NCT06679049?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-04-30. Estimated completion is 2026-12-01.

What conditions does trial NCT06679049 study?

This clinical trial studies the following conditions: Tibial Fractures.

What interventions are being tested in trial NCT06679049?

The interventions under investigation include: micromotion intramedullary nail cohort (PROCEDURE), standard intramedullary nail cohort (PROCEDURE).

Who is sponsoring clinical trial NCT06679049?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06679049 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tibial Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06679049's enrollment target sits among peer trials

100 7th of 12 higher than 6 of 12 other Tibial Fractures trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tibial Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06679049, the US trial registry maintained by the National Library of Medicine. NCT06679049 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.